publication . Article . 2019

Oral contraceptives and menopausal hormone therapy as breast cancer risk categories

Vуsotskaya, I. V.; Letyagin, V. P.; Vorotnikov, I. K.; Kirsanov, V. U.; Gladilina, I. A.; Kim, E. A.;
Open Access
  • Published: 06 Sep 2019 Journal: Tumors of female reproductive system, volume 15, pages 42-51 (issn: 1994-4098, eissn: 1999-8627, Copyright policy)
  • Publisher: Publishing House ABV Press
The research provided includes analysis of the current state of the problem on the use of oral contraceptives and menopausal hormone therapy. These therapeutic options were evaluated in terms of their importance for the risk of breast cancer. The possibility of using these drugs in a cohort of high-risk patients (women with family history of breast cancer) and in the group of patients with benign pathology was analyzed as well. Modern trends of menopausal hormone therapy prescription in different clinical situations were determined.
Persistent Identifiers
free text keywords: oral contraceptives, menopausal hormonal therapy, risk factors, breast cancer, brca1/2 genes, Oncology, medicine.medical_specialty, medicine, business.industry, business, Benign pathology, Family history, Menopausal hormone therapy, Cohort, Medical prescription, Breast cancer, medicine.disease, Internal medicine, lcsh:Gynecology and obstetrics, lcsh:RG1-991
Any information missing or wrong?Report an Issue